New Innovative VC Sustained Release Tablet | World’s First FDA approved ZJ1 VC
The brand new ZJ1 Vitamin C was developed by the Zhong Ji International Medical Group (US.). This innovation was granted approval by the FDA and is the world’s first FDA approved VC Sustained Release Tablet.
World’s First and Only FDA approved VC Sustained Release Supplements
What are the advantages of the ZJ1 Vitamin C compared to similar products on the market?
Dr. Leslie Guo, the deputy director of the Asian Integrated Cell Laboratory and deputy director of the Chinese Center of Stanford University Translational Medicine Center, stated that “Humans, primates alike cannot self-generate Vitamin C and hence must consume Vitamin C through their diets and medical supplements. Since the human body require a large amount of VC and VC is absorbed quickly in our digestive track, we need to redose VC multiple times a day in order to maintain a sustained and steady level of VC in our bloodstream. It is inconvenient and furthermore, it is difficult to control and maintain the clinical requirement of VC level in our body through this way of supplementing.”
The main advantage of ZJ1 Vitamin C over similar products is its ability to maintain a steady level of VC concentration in our bloodstream. The consumption of only one tablet once a day is sufficient to satisfy the human body’s daily requirement of Vitamin C.
·ZJ1 Vitamin C adopts the most advanced sustained drug release technology. VC is slowly released through the bloodstream which enables our human body to absorbed required nutrients.
· ZJ1 Vitamin C guarantees continuous effectiveness through maintaining stable VC concentration in the bloodstream. Its effects are prolonged and greater drug effects are achieved.
· ZJ1 Vitamin C can delay the release of VC, which lessens the stimulation to the digestive system, thereby protecting the human body.
The VC Sustained Release Tablet is convenient to take, absorbed steadily and has high bioavailability. These characteristics makes it the most suitable for children, elderlies and people who have difficulty swallowing pills.
Professor Hartmut Michel, Noble Prize winner and Chief Technology Officer of Hong Kong Zhong Ji International Medical Group, stated “ This type of ZJ1 VC effectively supplements the required amount of VC in the human body, efficiently strengthening immunity, is FDA approved, 5 times better absorbed generating 10 times effectiveness. It possesses great competitive advantages in the VC Supplements Market.”
Since the production process of ZJ1 Vitamin C is complicated, has high technical requirements and a strict quality standard, the current manufacturer can only supply for 30,000 users.